Cisco to Acquire Springpath

Cisco to Acquire Springpath

Cisco said Monday it plans to acquire Springpath, a Sunnyvale-based developer of hyperconvergence software for $320 million in cash and assumed equity awards, plus additional retention-based incentives. Springpath has developed a distributed file system purpose-built for hyperconvergence that enables server-based storage systems. Cisco said the acquisition will allow it to continue to deliver next-generation data center innovation to its customers. The companies have worked together since early 2016 to launch […]

Read More ˃
Tracon Pharmaceuticals Reports Positive Results from Trial of TRC105

Tracon Pharmaceuticals Reports Positive Results from Trial of TRC105

Tracon Pharmaceuticals has reported positive results from the National Cancer Institute (NCI) phase 1/2 trial of TRC105 and Nexavar (sorafenib) in hepatocellular cancer (HCC). NCI study researchers concluded that the combination of TRC105 and Nexavar was well-tolerated at the recommended single agent doses of both drugs, and that encouraging evidence of activity was observed. The data “suggest that the combination of TRC105 and Nexavar is active in patients with HCC […]

Read More ˃
Check Point Software Extends Share Buyback Program

Check Point Software Extends Share Buyback Program

Check Point Software Technologies, a network cyber security vendor globally, said early Friday that it has authorized an extension to its on-going share repurchase program. Under the updated plan, effective immediately, Check Point is authorized to continue to buy back up to $250 million of ordinary shares each quarter, up to $1 billion. From April 1, 2016 through June 30, 2017, Check Point bought back 14 million shares for an […]

Read More ˃
NovoCure Signs Contract With Austrian Insurers

NovoCure Signs Contract With Austrian Insurers

NovoCure said Tuesday it has signed a contract with the Federation of the Austrian Social Insurance Institutions, which grants reimbursement across Austria for Optune, Novocure’s Tumor Treating Fields delivery system, for the treatment of adults with newly diagnosed glioblastoma, a brain tumor. All 18 Austrian insurance funds have agreed to participate in the contract, the company said on Tuesday. Thus us Novocure’s first national reimbursement for Optune. The shares rose […]

Read More ˃
Asian ADRs Trade Lower

Asian ADRs Trade Lower

American depository receipts of Asian stocks were trading 0.20% lower at 167.86 on the Bank of New York Mellon Asia ADR Index on Thursday. In North Asia, the gainers were led by fabless semiconductor company Himax Technologies (HIMX), and solar equipment company SPI Energy (SPI), which rose 6.7% and 5.4% respectively. They were followed by biopharmaceutical company Beigene (BGNE), up 1.8%, and telecommunications company China Unicom (CHU), up 1.6%. The […]

Read More ˃
uniQure Buys Back Rights To Hemophilia B Treatment In Europe

uniQure Buys Back Rights To Hemophilia B Treatment In Europe

uniQure, a gene therapy developer, said it has reached a deal with the Chiesi Group to reacquire the rights to co-develop and commercialize its hemophilia B gene therapy in Europe and other select territories and to terminate their co-development and license agreement. uniQure will be responsible for all future development costs, including approximately $3 million of expenses in 2017 that would have otherwise been shared with Chiesi. The company said […]

Read More ˃